A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
Clinical trial NCT07001384 · RECRUITING
Trial details
- NCT number
- NCT07001384
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-08
- Primary completion
- 2031-08-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.